Insider Stock Trading History of Bryce Richard Paul


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bryce Richard Paul since year 2005. The trader's CIK number is 1553037. At the time of this reporting, Bryce Richard Paul is the SR VP, CLINICAL RESEARCH & DEV of Puma Biotechnology, Inc. . (stock ticker symbol PBYI). See this page for all insider trading activities at Puma Biotechnology, Inc. .


Stock purchases, sales, and option exercises reported by insider Bryce Richard Paul since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-29 PBYI Puma Biotechnology, Inc. Option Ex 15,000 11.30 169,500
2017-09-29 PBYI Puma Biotechnology, Inc. Sale 15,000 120.00 1,800,000
2017-09-06 PBYI Puma Biotechnology, Inc. Option Ex 1,000 11.30 11,300
2017-09-07 PBYI Puma Biotechnology, Inc. Option Ex 14,000 11.30 158,200
2017-09-06 PBYI Puma Biotechnology, Inc. Sale 1,000 100.00 100,000
2017-09-07 PBYI Puma Biotechnology, Inc. Sale 14,000 100.10 1,401,400
2017-07-20 PBYI Puma Biotechnology, Inc. Sale 1,998 94.84 189,490
2017-07-03 PBYI Puma Biotechnology, Inc. Option Ex 5,000 11.30 56,500
2017-07-03 PBYI Puma Biotechnology, Inc. Sale 5,000 87.10 435,500
2017-01-20 PBYI Puma Biotechnology, Inc. Sale 2,293 33.23 76,207
2015-07-06 PBYI Puma Biotechnology, Inc. Option Ex 3,000 11.30 33,900
2015-07-06 PBYI Puma Biotechnology, Inc. Sale 3,000 110.03 330,084
2014-04-09 PBYI Puma Biotechnology, Inc. Buy 2 87.35 174
2014-04-11 PBYI Puma Biotechnology, Inc. Buy 28 82.49 2,309

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bryce Richard Paul (SR VP, CLINICAL RESEARCH & DEV of Puma Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.